Post-Traumatic Stress Disorder (PTSD) Epidemiology
Key Highlights
- Post-traumatic stress disorder (PTSD) is a psychological condition resulting from exposure to severe stressors like combat or natural disasters, affecting the body, mind, and behaviour. Its development is influenced by factors such as trauma severity, gender, and genetic and epigenetic elements.
- PTSD symptoms may start within 1 month of a traumatic event, but sometimes symptoms may not appear until years after the event. The symptoms are generally grouped into four types: Intrusive memories, avoidance, negative changes in thinking and mood, and changes in physical and emotional reactions.
- To diagnose PTSD, the doctor will likely perform a physical exam to check for medical problems that may be causing the symptoms.
- In 2024, the diagnosed prevalent cases of PTSD were approximately 5,500,000 cases in the 7MM, which will increase by 2034.
- In the 7MM, the highest number of diagnosed prevalent cases of PTSD were observed in the US with ~4,000,000 cases.
- In the US, the total gender-specific cases of PTSD were ~3,200,000 and ~6,500,000 in males and females, respectively, in 2024.
- In the US, the diagnosed prevalent cases of PTSD were ~5,400,000 in 2024.
DelveInsight’s “Post-traumatic stress disorder (PTSD)” report delivers an in-depth understanding of Post-traumatic stress disorder (PTSD), historical and forecasted epidemiology in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
The table given below further depicts the key segments provided in the report:
|
Study Period |
2021-2034 |
|
Forecast Period |
2025–2034 |
|
Geographies Covered |
US, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan |
|
Epidemiology |
Segmented by: • Total 12-month Prevalent cases • Diagnosed prevalent cases • Severity-specific cases • Gender-specific cases • Age-specific cases |
Post-traumatic stress disorder (PTSD): Disease Understanding
Post-traumatic stress disorder (PTSD) Overview, and Diagnosis
PTSD is a psychiatric disorder that can occur in people who have experienced or witnessed a traumatic event such as a natural disaster, a serious accident, a terrorist act, war/combat, or rape, or who have been threatened with death, sexual violence, or serious injury. People with PTSD have intense, disturbing thoughts and feelings related to their experience that last long after the traumatic event has ended. They may relive the event through flashbacks or nightmares; they may feel sadness, fear, or anger, detached or estranged from others. People with PTSD may avoid situations or people that remind them of the traumatic event and may have strong negative reactions to something as ordinary as a loud noise or an accidental touch.
PTSD symptoms may start within 1 month of a traumatic event, but sometimes symptoms may not appear until years after the event. These symptoms cause significant problems in social or work situations and relationships. They can also interfere with the ability to go about the normal daily tasks, and the symptoms are generally grouped into four types: intrusive memories, avoidance, negative changes in thinking and mood, and changes in physical and emotional reactions. Symptoms can vary over time or from person to person.
PTSD is diagnosed when symptoms last for more than one month after a traumatic event. The diagnosis is based on the reported symptoms and any resulting functional impairments. When PTSD symptoms are present, the doctor begins by gathering a thorough medical history and performing a physical examination. Although there are no specific lab tests for PTSD, doctors may use tests to rule out other physical conditions that could explain the symptoms. If no physical cause is identified, the individual may be referred to a psychiatrist, psychologist, or another mental health professional who is trained to diagnose and treat psychiatric conditions. These specialists use specialized interviews and assessment tools to evaluate the person for PTSD or other mental health disorders.
Post-traumatic stress disorder (PTSD) Epidemiology
The PTSD epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by Total 12-month prevalent cases, Diagnosed prevalent cases, gender-specific cases, age-specific cases, and severity-specific cases in the United States, EU4 countries (Germany, France, Italy, and Spain) and the United Kingdom, and Japan from 2021 to 2034.
• The total diagnosed cases of PTSD in the US were around 4,000,000 cases in 2024.
• In the US, the total age-specific cases of PTSD were ~2,400,000, ~2,600,000, ~3,600,000, and ~1,040,400 in 18–29, 30–44, 45–59, and 60+ age groups, respectively, in 2024.
• France had the highest diagnosed prevalent cases of PTSD among the EU4 and the UK, accounting for more than 35% of cases in 2024.
• In 2024, the total treated cases of PTSD in the US were around 1,800,000.
Scope of the Report
- The report covers a segment of key events, an executive summary, and a descriptive overview of Post-traumatic stress disorder (PTSD), explaining its causes, signs and symptoms, pathogenesis, and currently available therapies.
- Comprehensive insight into the epidemiology segments and forecasts, the future growth potential of diagnosis rate, and disease progression have been provided.
- A detailed review of current challenges in establishing diagnosis and diagnosis rate is provided.
Post-traumatic stress disorder (PTSD) Report Insights
- Patient Population
- Country-wise Epidemiology Distribution
Post-traumatic stress disorder (PTSD) Report Key Strengths
- Ten-year Forecast
- The 7MM Coverage
- Post-traumatic stress disorder (PTSD) Epidemiology Segmentation
Post-traumatic stress disorder (PTSD) Report Assessment
- Epidemiology Segmentation
- Current Diagnostic Practices
FAQs
Epidemiology Insights
- What are the disease risks, burdens, and unmet needs of Post-traumatic stress disorder (PTSD)? What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Post-traumatic stress disorder (PTSD)?
- What is the historical and forecasted Post-traumatic stress disorder (PTSD) patient pool in the United States, EU4 (Germany, France, Italy, Spain) and the United Kingdom, and Japan?
- What is the diagnostic pattern of Post-traumatic stress disorder (PTSD)?
- Which clinical factors will affect Post-traumatic stress disorder (PTSD)?
- Which factors will affect the increase in the diagnosis of Post-traumatic stress disorder (PTSD)?
Reasons to buy
- Insights on disease burden, details regarding diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
- To understand the change in Post-traumatic stress disorder (PTSD) cases in varying geographies over the coming years.
- A detailed overview of total prevalent cases of Post-traumatic stress disorder (PTSD), Diagnosed prevalent cases of Post-traumatic stress disorder (PTSD), type specific cases of Post-traumatic stress disorder (PTSD), gender specific cases of Post-traumatic stress disorder (PTSD), age specific cases of Post-traumatic stress disorder (PTSD), and total treated cases of Post-traumatic stress disorder (PTSD) is included.
- To understand the perspective of key opinion leaders around the current challenges with establishing the diagnosis and insights on the treatment-eligible patient pool.
- Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.

